Pharma IQ Members


Immunogenicity- IQPC
The FDA has confirmed it will be providing a presentation on the FDA Guidance for Industry White Paper: Ensuring Compliance in Assay Development Immunogenicity Testing. Dr Jennifer Reed, Team Leader, CBER FDA, will be delivering the information via a presentation at the Annual Immunogenicity conference, which takes place on the 21st-23rd June...Full Article »